Search

Author/Creator Resche-Rigon, M

2. OP01 Withdrawal of infliximab or anti-metabolite therapy in Crohn's Disease patients in sustained remission on combination therapy: A randomized unblinded controlled trial (SPARE). (21st January 2022)

Authors:
Louis J, E; Resche-Rigon, M; Laharie, D; Satsangi, J; Ding, N; Preiss, J; D'Haens, G; Picon, L; Bossuyt, P; Vuitton, L; Irving, P; Bouhnik, Y; Viennot, S; Lamb, C; Pollock, R; Baert, F; Nachury, M; Mathurin, F; Gilletta, C; Colombel, J F
Journal:
Journal of Crohn's and colitis
Issue:
Volume 16(2022)Supplement 1
Page Start:
i001
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. OP0134 Long term outcome and prognosis factors of complications in takayasu's arteritis: multicenter study of 318 patients. (15th June 2017)

Authors:
Comarmond, C; Biard, L; Lambert, M; Mekinian, A; Ferfar, Y; Kahn, J-E; Benhamou, Y; Chiche, L; Koskas, F; Cluzel, P; Hachulla, E; Messas, E; Resche-Rigon, M; Mirault, T; Cacoub, P; Saadoun, D
Journal:
Annals of the rheumatic diseases
Issue:
Volume 76(2017)Supplement 2
Page Start:
108
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗